PHLPP2 and lung cancer: Furthermore, the Kaplan‐Meier plotter online tool was used to validate the effect of PHLPP2 on lung cancer survival (n = 1926).26 The results consistently show that patients with elevated levels of PHLPP2 expression had longer OS (P = 0.00013) and post progression survival (PPS) (P = 0.012) than those with low PHLPP2 expression levels (Fig 3b).